DNA adduct formation from tobacco-specific N-nitrosamines

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 424, Issue 1-2, 1999, Pages 127-142

  Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

4 (Methylnitrosamino) 1 (3 pyridyl) 1 butanone (NNK); DNA adduct; DNA methylation; DNA pyridyloxobutylation; N' Nitrosonornicotine (NNN); Tobacco specific N nitrosamine

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; NITROSAMINE; NITROSONORNICOTINE; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; DNA METHYLATION; HUMAN; HUMAN TISSUE; LUNG; METABOLIC ACTIVATION; METHYLATION; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RAT;

ANIMALS; CARCINOGENS; CRICETINAE; DNA ADDUCTS; DNA DAMAGE; DNA METHYLATION; HUMANS; MICE; NITROSAMINES; PLANTS, TOXIC; RATS; TOBACCO;

ANIMALIA; NICOTIANA TABACUM; RODENTIA;

EID: 0033535375     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00014-7     Document Type: Article

References (95)

1. Hoffmann D., Hecht S.S. Nicotine-derived N-nitrosamines and tobacco related cancer: current status and future directions. Cancer Res. 45:1985;935-944.
2. Hecht S.S., Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 9:1988;875-884.
3. Hoffmann D., Brunnemann K.D., Prokopczyk B., Djordjevic M.V. Tobacco-specific N-nitrosamines and areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health. 41:1994;1-52.
4. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11:1998;559-603.
5. Hecht S.S., Carmella S.G., Murphy S.E., Akerkar S., Brunnemann K.D., Hoffmann D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. New Engl. J. Med. 329:1993;1543-1546.
6. W.D. Parsons, S.G. Carmella, S. Akerkar, L.E. Bonilla, S.S. Hecht, A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the urine of hospital workers exposed to environmental tobacco smoke, Cancer Epidemiol., Biomarkers and Prev., in press (1998).
7. International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, Tobacco smoking, International Agency for Research on Cancer, Lyon, France (1986).
8. World Cancer Research Fund/American Institute for Cancer Research Food, Nutrition and the Prevention of Cancer: a Global Perspective, 37 (1997).
9. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics 1998. CA. 48:1998;6-29.
10. Anonymous, Cigarette smoking among adults - United States, 1994, MMWR 45 (1996) 588-590.
11. Thun M.J., Lilly C.A., Flannery J.T., Calle E.E., Flanders W.D., Heath C.W. Cigarette smoking and changes in the histopathology of lung cancer. J. Natl. Cancer Inst. 89:1997;1580-1586.
12. Hecht S.S., Hoffmann D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv. 8:1989;273-294.
13. International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 37, Tobacco habits other than smoking: betel quid and areca nut chewing and some related nitrosamines, International Agency for Research on Cancer, Lyon, France, (1985).
14. Spiegelhalder B., Bartsch H. Tobacco-specific nitrosamines. Eur. J. Cancer Prev. 5:1996;33-38.
15. Hoffmann D., Djordjevic M.V., Fan J., Zang E., Glynn T., Connolly G.N. Five leading U.S. commercial brands of moist snuff in 1994 - assessment of carcinogenic N-nitrosamines. J. Natl. Cancer Inst. 87:1995;1862-1869.
16. Idris A.M., Nair J., Ohshima H., Friesen M., Brouet I., Faustman E.M., Bartsch H. Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak). Carcinogenesis. 12:1991;1115-1118.
17. Preston-Martin S., Correa P. Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv. 8:1989;459-473.
18. Magee P.N. Nitrosamines and human cancer: introduction and overview. Eur. J. Cancer Prev. 5:1996;7-10.
19. Bartsch H., Spiegelhalder B. Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview. Eur. J. Cancer Prev. 5:1996;11-18.
20. R. Preussmann, B.W. Stewart, N-nitroso carcinogens, in: C.E. Searle (Ed.), Chemical Carcinogenesis ACS, Washington, DC (1984), pp. 643-828.
21. S.S. Hecht, N-Nitrosamines, in: W.N. Rom (Ed.), Environmental and Occupational Medicine, 3rd edn., Lippincott-Raven, 1998.
22. Murphy S.E., Spina D.A., Nunes M.G., Pullo D.A. Glucuronidation of 4-(hydroxymethyl)-nitrosamino-1-(3-pyridyl)-1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital treated rats. Chem. Res. Toxicol. 8:1995;772-779.
23. Peterson L.A., Mathew R., Murphy S.E., Trushin N., Hecht S.S. In vivo and in vitro persistence of pyridyloxobutyl DNA adducts from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 12:1991;2069-2072.
24. Hecht S.S., Chen C.B. Hydrolysis of model compounds for α-hydroxylation of the carcinogens, N-nitrosopyrrolidine and N′-nitrosonornicotine. J. Org. Chem. 44:1979;1563-1566.
25. Hecht S.S., Lin D. Comparative mutagenicity of 4-(carbethoxynitrosamino)-4-(3-pyridyl)butanal and 4-(carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone, model compounds for α-hydroxylation of N′-nitrosonornicotine. Carcinogenesis. 7:1986;611-614.
26. Peterson L.A., Carmella S.G., Hecht S.S. Investigations of metabolic precursors to hemoglobin and DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 11:1990;1329-1333.
27. Spratt T.E., Peterson L.A., Confer W.L., Hecht S.S. Solvolysis of model compounds for α-hydroxylation of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: evidence for a cyclic oxonium ion intermediate in the alkylation of nucleophiles. Chem. Res. Toxicol. 3:1990;350-356.
28. 6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res. 51:1991;5557-5564.
29. Murphy S.E., Heiblum R., Trushin N. Comparative metabolism of N′-nitrosonornicotine and 4-methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat oral tissue and esophagus. Cancer Res. 50:1990;4685-4691.
30. Hecht S.S., Spratt T.E., Trushin N. Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco specific nitrosamines 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Carcinogenesis. 9:1988;161-165.
31. 2-(pyridyloxobutyl)deoxyguanosine adducts in DNA of tissues exposed to tritium-labeled 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Chem. Res. Toxicol. 2:1989;169-173.
32. Foiles P.G., Peterson L.A., Miglietta L.M., Ronai Z. Analysis of mutagenic activity and ability to induce replication of polyoma DNA sequences by different model compounds of the carcinogenic tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Mut. Res. 279:1992;91-101.
33. 6-alkylguanine-DNA alkytransferase. Chem. Res. Toxicol. 10:1997;562-567.
34. Hecht S.S., Trushin N. DNA and hemoglobin alkylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its major metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis. 9:1988;1665-1668.
35. Murphy S.E., Palomino A., Hecht S.S., Hoffmann D. Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res. 50:1990;446-5452.
36. Foiles P.G., Akerkar S.A., Carmella S.G., Kagan M., Stoner G.D., Resau J.H., Hecht S.S. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem. Res. Toxicol. 4:1991;64-368.
37. Trushin N., Rivenson A., Hecht S.S. Evidence supporting the role of DNA pyridyloxobutylation in rat nasal carcinogenesis by tobacco specific nitrosamines. Cancer Res. 54:1994;1205-1211.
38. Staretz M.E., Foiles P.G., Miglietta L.M., Hecht S.S. Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogensis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate. Cancer Res. 57:1997;259-266.
39. S.S. Hecht, L.A. Peterson, T.E. Spratt, Tobacco-specific nitrosamines, in: K. Hemminki, A. Dipple, D.E.G. Shuker, F.F. Kadlubar, D. Segerbäck, H. Bartsch (Eds.), DNA Adducts: Identification and Biological Significance, IARC Scientific Publications, Lyon, France, International Agency for Research on Cancer 125 (1994), 91-106.
40. 2-tetrahydropyranyl adducts. Chem. Res. Toxicol. 8:1995;607-616.
41. 2-tetrahydropyranyl adducts in the reactions of α-acetoxy-N-nitrosopyrrolidine and α-acetoxy-N-nitrosopiperidine with DNA. Chem. Res. Toxicol. 8:1995;617-624.
42. Hecht S.S., Lin D., Chuang J., Castonguay A. Reactions with deoxyguanosine of 4-(carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone, a model compound for α-hydroxylation of tobacco specific nitrosamines. J. Amer. Chem. Soc. 108:1986;1292-1295.
43. 6-methylguanine. Cancer Res. 53:1993;2780-2785.
44. 6-alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol. 9:1996;949-953.
45. A. Castonguay, R. Tharp, S.S. Hecht, Kinetics of DNA methylation by the tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats, in: I.K. O'Neill, R.C. Von Borstel, C.T. Miller, J. Long, H. Bartsch (Eds.), N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, International Agency for Research on Cancer, Lyon, France (1984), pp. 805-810.
46. Belinsky S.A., White C.M., Boucheron J.A., Richardson F.C., Swenberg J.A., Anderson M. Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 46:1986;1280-1284.
47. Devereux T.R., Anderson M.W., Belinsky S.A. Factors regulating activation and DNA alkylation by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and nitrosodimethylamine in rat lung and isolated lung cells, and their relationship to carcinogenicity. Cancer Res. 48:1988;4215-4221.
48. Belinsky S.A., White C.M., Devereux T.R., Swenberg J.A., Anderson M.W. Cell-selective alkylation of DNA in rat lung following low dose exposure to the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 47:1987;1143-1148.
49. 6-methylguanine in rat pulmonary cells. Carcinogenesis. 9:1988;2053-2058.
50. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 50:1990;3772-3780.
51. Guo Z., Smith T.J., Ishizaki H., Yang C.S. Metabolism of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytochrome P450IIB1 in a reconstituted system. Carcinogenesis. 12:1991;2277-2282.
52. Staretz M.E., Koenig L., Hecht S.S. Effects of long term phenethyl isothiocyanate treatment on microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis. 18:1997;1715-1722.
53. Hecht S.S., Chen C.B., Ohmori T., Hoffmann D. Comparative carcinogenicity in F344 rats of the tobacco specific nitrosamines, N′-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 40:1980;298-302.
54. Hecht S.S., Trushin N., Castonguay A., Rivenson A. Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res. 46:1986;498-502.
55. Hoffmann D., Rivenson A., Amin S., Hecht S.S. Dose-response study of the carcinogenicity of tobacco-specific N-nitrosamines in F344 rats. J. Cancer Res. Clin. Oncol. 108:1984;81-86.
56. Belinsky S.A., White C.M., Trushin N., Hecht S.S. Cell specificity for the pulmonary metabolism of tobacco-specific nitrosamines in the Fisher rat. Carcinogenesis. 10:1989;2269-2274.
57. Belinsky S.A., Walker V.E., Maronpot R.R., Swenberg J.A., Anderson M.W. Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to the tobacco specific nitrosamine 4-(N-methylN-nitrosamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia. Cancer Res. 47:1987;6058-6065.
58. Smith T.J., Guo Z., Hong J.-Y., Ning S.M., Thomas P.E., Yang C.S. Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. Carcinogenesis. 13:1992;1409-1414.
59. Hecht S.S., Morse M.A., Amin S., Stoner G.D., Jordan K.G., Choi C.-I., Chung F.L. Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis. 10:1989;1901-1904.
60. Belinsky S.A., Devereux T.R., Maronpot R.R., Stoner G.D., Anderson M.W. The relationship between the formation of promutagenic adducts and the activation of the K-ras proto-oncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res. 49:1989;5305-5311.
61. 6-methylguanine DNA adduct levels and K-ras activation in lung tumors from resistant and susceptible mouse strains. Mol. Carcinogenesis. 8:1993;177-185.
62. Hecht S.S., Jordan K.G., Choi C.-I., Trushin N. Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesis. 11:1990;1017-1020.
63. Morse M.A., LaGreca S.D., Amin S.G., Chung F.-L. Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res. 50:1990;2613-2617.
64. 6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Cancer Res. 49:1989;2894-2897.
65. Morse M.A., Eklind K.I., Hecht S.S., Jordan K.G., Choi C.-I., Desai D.H., Amin S.G., Chung F.-L. Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice. Cancer Res. 51:1991;1846-1850.
66. Liu L., Castonguay A., Gerson S.L. Lack of correlation between DNA methylation and hepatocarcinogenesis in rats and hamsters treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 13:1992;2137-2140.
67. 32P-postlabeling assay Carcinogenesis. 14:1993;545-550.
68. 32P-postlabelling assay of N7 methyldeoxyguanosine Cancer Res. 50:1990;6580-6584.
69. 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA Carcinogenesis. 14:1993;151-154.
70. Kato S., Bowman E., Harrington A.M., Blomeke B., Shields P.G. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Inst. 87:1995;902-907.
71. Blomeke B., Greenblatt M.J., Doan V.D., Bowman E.D., Murphy S.E., Chen C.C., Kato S., Shields P.G. Distribution of 7-alkyl-2′-deoxyguanosine adduct levels in human lung. Carcinogenesis. 17:1996;741-748.
72. Petruzzelli S., Tavanti L., Celi A., Giuntini C. Detection of N7-methyldeoxyguanosine adducts in human pulmonary alveolar cells. Am. J. Respir. Cell Mol. Biol. 15:1996;216-223.
73. Smith T.J., Stoner G.D., Yang C.S. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res. 55:1995;5566-5573.
74. 6-methyldeoxyguanosine in human placental DNA. Cancer Res. 48:1988;4184-4188.
75. Umbenhauer D., Wild C.P., Montesano R., Saffhill R., Boyle J.M., Huh N., Kirstein U., Thomale J., Rajewsky M.F., Lu S.H. Methyldeoxyguanosine in oesphageal DNA among individuals at high risk of oesphageal cancer. Inter. J. Cancer. 36:1985;661-665.
76. Szyfter K., Hemminki K., Szyfter W., Szmeja Z., Banaszewski J., Pabiszczak M. Tobacco smoke-associated N7-alkylguanine in DNA of larynx tissue and leucocytes. Carcinogenesis. 17:1996;501-506.
77. 4-ethylthymine in human liver and peripheral blood leukocyte DNA. Carcinogenesis. 16:1995;1277-1280.
78. 6-Methylguanine in blood leucocyte DNA: an association with the geographic prevalence of gastric cancer and with low levels of serum pepsinogen A, a marker of severe chronic atrophic gastritis, Carcinogenesis 15 (1994) 1815-1820.
79. Mustonen R., Hemminki K. 7-Methylguanine levels in DNA of smokers' and non-smokers' total white blood cells, granulocytes and lymphocytes. Carcinogenesis. 13:1992;1951-1955.
80. Fay L.B., Leaf C.D., Gremaud E., Aeschlimann J.-M., Steen C., Shuker D.E.G., Turesky R.J. Urinary excretion of 3-methyladenine after consumption of fish containing high levels of dimethylamine. Carcinogenesis. 18:1997;1039-1044.
81. Stillwell W.G., Glogowski J., Xu H.-X., Wishnok J.S., Zavala D., Montes G., Correa P., Tannenbaum S.R. Urinary excretion of nitrate, N-nitrosoproline, 3-methyladenine, and 7-methyl-guanine in a Colombian population at high risk for stomach cancer. Cancer Res. 51:1991;190-194.
82. Prevost V., Shuker D.E.G. Cigarette smoking and urinary 3-alkyladenine excretion in man. Chem. Res. Toxicol. 9:1996;439-444.
83. Kopplin A., Eberle-Adamkiewicz G., Glüsenkamp K.-H., Nehls P., Kirstein U. Urinary excretion of 3-methyladenine and 3-ethyladenine after controlled exposure to tobacco smoke. Carcinogenesis. 16:1995;2637-2641.
84. Demkowicz-Dobrzanski K., Castonguay A. Comparison of DNA alkali-labile sites induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl) butanal in rat hepatocytes. Carcinogenesis. 12:1991;2135-2140.
85. Joquera R., Castonguay A., Schuller H.M. DNA single-strand breaks and toxicity induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or N-nitrosodimethylamine in hamster and rat liver. Carcinogenesis. 15:1994;389-394.
86. Chung F.-L., Xu Y. Increased 8-hydroxydeoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 13:1992;1269-1272.
87. Sipowicz M.A., Amin S., Desai D., Kasprzak K.S., Anderson L.M. Oxidative DNA damage in tissues of pregnant female mice and fetuses caused by tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer Lett. 117:1997;87-91.
88. Xu Y., Ho C.T., Amin S.G., Han C., Chung F.-L. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res. 52:1992;3875-3879.
89. Weitberg A.B., Corvese D. Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin. Genet. 43:1993;88-89.
90. Asami S., Hirano T., Yamaguchi Y., Itoh H., Kasai N.H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res. 56:1996;2546-2549.
91. Asami S., Manabe H., Miyake J., Tsurudome Y., Hirano T., Yamaguchi R., Itoh H., Kasai N.H. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis. 18:1997;1763-1766.
92. Patten C., Smith T., Friesen M., Tynes R., Yang C., Murphy S. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N′-nitrosonornicotine α-hydroxylation by human liver microsomes. Carcinogenesis. 18:1997;1623-1630.
93. Löfberg B., Brittebo E.B., Tjälve H. Localization and binding of N′-nitrosonornicotine metabolites in the nasal region and in some other tissues of Sprague-Dawley rats. Cancer Res. 42:1982;2877-2883.
94. Diaz Gómez M.I., Tamayo D., Castro J.A. Administration of N-nitrosodimethylamine, N-nitrosopyrrolidine, or N′-nitrosonornicotine to nursing rats: their interactions with liver and kidney nucleic acids from sucklings. J. Natl. Cancer Inst. 76:1986;1133-1136.
95. Castonguay A., Foiles P.G., Trushin N., Hecht S.S. Study of DNA methylation by tobacco-specific N-nitrosamines. Environ. Health Perspect. 62:1985;197-202.